Safety and Effectiveness of Micardis [telmisartan] Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients.

Trial Profile

Safety and Effectiveness of Micardis [telmisartan] Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jun 2014

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 19 Feb 2010 Actual number of patients changed from 3002 to 3148 as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Planned number of patients changed from 3000 to 3002 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top